drugset / Trial / NCT01500122
Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX®
NaSingle-groupOpen-label
Summary
The primary objectives of the study are: * To compare the pharmacokinetic profiles of RhuDex administered as two novel oral formulations * To identify the lead formulation and optimise the pharmacokinetic profile by modifying the quantitative composition of that formulation * Optional: To assess the intravenous pharmacokinetics of RhuDex following administration of an IV microtracer of \[14C\]RhuDex
Timeline
- Start
- 2011-12
- Primary completion
- 2012-03
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RhuDex® | Small molecule | — | Oral |
Indications
No indication recorded.